Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
31,2 TWD | +1,46% | -0,32% | +4,17% |
Attività
Vendite per attività
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
New Drug Translation Development Services
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -82,89% |
Vendite per regione
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Taiwan
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -82,89% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Hai Shan Jian
CEO | Chief Executive Officer | - | 31/07/13 |
Wen Chi Lee
FOU | Founder | - | 31/07/13 |
Fu Pin Wu
DFI | Director of Finance/CFO | - | 21/04/22 |
Shu Yueh Lin
COO | Chief Operating Officer | - | 01/03/22 |
Hui Ling Chang
IRC | Investor Relations Contact | - | 15/04/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ta Kun Shih
BRD | Director/Board Member | 72 | 15/03/22 |
Hsiu Lien Lin
BRD | Director/Board Member | - | 15/03/22 |
Hai Shan Jian
CEO | Chief Executive Officer | - | 31/07/13 |
Wen Chi Lee
FOU | Founder | - | 31/07/13 |
Liang Sheng Kan
BRD | Director/Board Member | - | 15/03/22 |
Hui Chin Tseng
BRD | Director/Board Member | - | 15/03/22 |
Yueh Hsuan Chan
BRD | Director/Board Member | - | 15/03/22 |
Meng Pin Tseng
BRD | Director/Board Member | - | 15/03/22 |
Te Hsing Hu
BRD | Director/Board Member | - | 15/03/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 115 754 000 | 115 754 000 ( 100,00 %) | 0 | 100,00 % |
Coordinate società
BRIM Biotechnology, Inc.
8/F 1, Alley 30, Lane 358, Ruiguang Road
114036, Taipei
+
http://www.brimbiotech.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+4,17% | 111 Mln | |
+30,38% | 684 Mrd | |
+26,51% | 568 Mrd | |
-4,36% | 361 Mrd | |
+19,30% | 329 Mrd | |
+3,73% | 284 Mrd | |
+16,70% | 240 Mrd | |
+8,78% | 208 Mrd | |
-7,93% | 200 Mrd | |
+7,68% | 166 Mrd |
- Borsa valori
- Azioni
- Azione 6885
- Società BRIM Biotechnology, Inc.